In a considerable number of studies, it has been claimed that the over expression of PPARγ in cancer cells is a determining factor in the favorable response rate of neoplastic cells to the anticancer drugs (Papadaki et al., 2005; Sato et al., 2000). Here, PPARG is linked to cancer.